ALVR — Allovir Balance Sheet

0.000.00%

Last trade - 00:00

HealthcareSpeculativeSmall CapNeutral

Annual balance sheet for Allovir, fiscal year end - December 31st, USD millions except per share, conversion factor applied.

	2019 December 31st	2020 December 31st	2021 December 31st	2022 December 31st	2023 December 31st
Period Length:	—	—	—	—	—
Source:	PROSPECTUS	10-K	10-K	10-K	10-K
Standards:	USG	USG	USG	USG	USG
Status:	Final	Final	Final	Final	Final
Cash and Equivalents
Short Term Investments
Cash and Short Term Investments	126	356	248	234	184
Net Total Accounts Receivable
Net Total Receivables	0.56	0.45	0.05	0.157	0.206
Prepaid Expenses
Total Other Current Assets
Total Current Assets	127	361	253	243	188
Gross Property, Plant And Equipment
Accumulated Depreciation
Net Property, Plant And Equipment	12.1	9.5	31.3	32.6	2.19
Other Long Term Assets
Total Assets	139	371	287	277	191
Accounts Payable
Accrued Expenses
Notes Payable / Short Term Debt
Total Other Current Liabilities
Total Current Liabilities	9.11	12.3	37.9	24.3	28.4
Total Long Term Debt
Total Debt
Total Other Liabilities
Total Liabilities	17.8	17.8	61.3	52.6	45
Redeemable Preferred Stock
Common Stock
Additional Paid In Capital
Retained Earnings (Accumulated Deficit)
Unrealized Gain / Loss
Other Equity
Total Equity	122	353	225	225	146
Total Liabilities & Shareholders' Equity	139	371	287	277	191
Total Common Shares Outstanding